Sun Pharmaceuticals reported INR22.41B in Cost of Sales for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Bharat Petroleum BPCL:IN 639.71B 85.15B
Cipla CIPLA:IN 18.22B 1.71B
Dr.Reddys Laboratories DRRD:IN 15.42B 962M
Jiangsu Hengrui Me. 600276:CH CH 910.4M 110.4M
Reliance Infra RELI:IN IR 1015370M 292880M
Sh Fosun Pharma 600196:CH CH 3.82B 147.55M
Sun Pharmaceuticals SUNP:IN IR 22407.6M 926.3M
UPL UPLL:IN 69.21B 28.04B